AR and prostate carcinoma: Moreover, miR-221/222 was involved in the progression from hormone-sensitive to castration-resistant prostate cancer by downregulating HECTD2 and RAB1A, which subsequently led to reprograming of AR signaling, and activation of EMT and new cyclins (32).